Tiova Inhaler: Advanced COPD Management with Tiotropium Bromide
| Product dosage: 200 MD | |||
|---|---|---|---|
| Package (num) | Per inhaler | Price | Buy |
| 6 | $12.78 | $76.66 (0%) | 🛒 Add to cart |
| 10 | $9.58
Best per inhaler | $127.76 $95.82 (25%) | 🛒 Add to cart |
The Tiova Inhaler is a prescription bronchodilator medication designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Its active ingredient, Tiotropium Bromide, is an anticholinergic agent that works by relaxing the muscles around the airways, making breathing easier for patients. This inhaler is a cornerstone in managing respiratory symptoms, helping to reduce exacerbations and improve overall lung function and quality of life. It is intended for regular daily use as part of a comprehensive COPD management plan under medical supervision.
Features
- Active Ingredient: Tiotropium Bromide (18 mcg per inhalation)
- Device Type: Pressurized Metered-Dose Inhaler (pMDI) with dose counter
- Mechanism of Action: Long-acting muscarinic antagonist (LAMA)
- Duration of Action: Provides 24-hour bronchodilation with once-daily dosing
- Formulation: Dry powder inhaler for efficient lung deposition
- Doses per Inhaler: 30 actuations per device
Benefits
- Significantly improves lung function (FEV1) within 30 minutes of use, with effects sustained for a full 24 hours.
- Reduces the frequency and severity of COPD exacerbations, potentially decreasing hospitalizations.
- Enhances exercise tolerance and overall quality of life by alleviating breathlessness during daily activities.
- Offers a convenient once-daily dosing regimen, improving adherence compared to multiple-daily therapies.
- Helps reduce dynamic hyperinflation (air trapping), allowing for more effective breathing patterns.
- Compatible with other COPD maintenance therapies, allowing for individualized treatment escalation.
Common use
Tiova Inhaler is primarily indicated for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD). It is used to manage symptoms such as shortness of breath, wheezing, and chronic cough. It is not intended for the relief of acute bronchospasm (rescue medication) but rather for prophylactic management to prevent symptoms from occurring. It may be prescribed as monotherapy or as part of combination therapy in patients with moderate to severe COPD.
Dosage and direction
The recommended dosage for adults is one inhalation (18 mcg) once daily, at the same time each day. Do not exceed the prescribed dose. Instructions for use: Remove the protective cap. Hold the inhaler upright and shake well before each use. Breathe out fully, away from the inhaler. Place the mouthpiece between your lips, forming a tight seal. While breathing in deeply and slowly through your mouth, press down firmly on the canister to release the medication. Hold your breath for 10 seconds, or as long as is comfortable, then breathe out slowly. Replace the protective cap after use. Rinse your mouth with water after each inhalation to help prevent oral thrush. The dose counter will show how many doses remain.
Precautions
Inform your physician if you have a history of narrow-angle glaucoma, prostatic hyperplasia, bladder neck obstruction, or renal impairment. Use with caution in patients with cardiovascular disorders such as coronary artery disease, cardiac arrhythmias, or hypertension. Monitor for signs of paradoxical bronchospasm; if it occurs, discontinue use immediately. This medication may cause dizziness or blurred vision; do not drive or operate machinery until you know how it affects you. Avoid getting the spray in your eyes, as it may cause pupil dilation and eye pain. Not recommended for use in children or adolescents under 18 years of age. Pregnant or breastfeeding women should use only if clearly needed and under strict medical supervision.
Contraindications
Tiova Inhaler is contraindicated in patients with a known hypersensitivity to tiotropium bromide, atropine or its derivatives, or any other component of the formulation. It should not be used for the treatment of acute episodes of bronchospasm (i.e., rescue therapy). Contraindicated in patients with a history of hypersensitivity reactions such as rash, urticaria, or angioedema to similar anticholinergic agents.
Possible side effect
Common side effects may include dry mouth (approximately 10-15% of patients), sinusitis, pharyngitis, and non-specific chest pain. Other reported side effects include constipation, dyspepsia, vomiting, urinary retention, tachycardia, palpitations, blurred vision, glaucoma, cough, and hoarseness. Allergic reactions such as skin rash, itching, and urticaria may occur rarely. Immediate medical attention is required if signs of a serious allergic reaction (e.g., difficulty breathing, swelling of the face/lips/tongue/throat) occur. Paradoxical bronchospasm (worsening of breathing immediately after inhalation) is a serious but rare side effect requiring discontinuation.
Drug interaction
Concomitant use with other anticholinergic-containing drugs (e.g., ipratropium, aclidinium) may potentiate adverse effects and is not recommended. Use with caution with other drugs that possess anticholinergic properties, such as antihistamines, antidepressants (tricyclics), and antipsychotics. Beta-blockers may antagonize the effects of bronchodilators and should be used with caution in COPD patients. There is a potential for additive interaction with drugs that prolong the QT interval. Inform your doctor about all prescription, non-prescription, and herbal products you are using.
Missed dose
If you miss a dose of Tiova Inhaler, take it as soon as you remember on the same day. If it is nearly time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining a consistent daily routine is important for optimal control of COPD symptoms.
Overdose
Overdose may lead to intensification of anticholinergic effects such as dry mouth, visual disturbances, tachycardia, urinary retention, and constipation. In severe cases, delirium, psychosis, or cardiac arrhythmias may occur. There is no specific antidote for tiotropium overdose. Treatment is supportive and symptomatic. Medical attention should be sought immediately. Dialysis is not likely to be effective due to high protein binding and large volume of distribution.
Storage
Store at room temperature (15-30°C). Keep the inhaler in the sealed foil pouch until first use to protect from moisture and light. Do not puncture or incinerate the canister, even when empty. Keep out of reach of children. Do not store in damp places like bathrooms. The inhaler should be discarded 3 months after removal from the foil pouch or when the dose counter reads “0”, whichever comes first.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Tiova Inhaler is a prescription medication and should be used only under the supervision of a qualified healthcare professional. Always follow your doctor’s instructions regarding dosage and usage. Do not initiate, discontinue, or change the dosage of any medicine without your doctor’s approval.
Reviews
“After six months on Tiova, my morning shortness of breath has significantly reduced. My spirometry results showed a 15% improvement in FEV1. The once-daily dosing is very convenient.” – Robert K., diagnosed with emphysema.
“As a respiratory therapist, I’ve observed consistent improvement in exercise tolerance among my patients using Tiova. The dose counter is a practical feature for adherence monitoring.” – Linda K., RRT.
“I experienced dry mouth initially, but it subsided after a few weeks. The improvement in my ability to perform daily tasks without gasping for air has been life-changing.” – Margaret T.
“Clinical trials demonstrate Tiova’s efficacy in reducing exacerbation rates by up to 22% compared to placebo. It remains a first-line option in our COPD treatment protocol.” – Dr. A. Sharma, Pulmonologist.